I have PC (originally Gleason 4+3 and PSA of 10) which has metasticised to a number of bones - pelvis, ribs, skull. I am taking Aberaterone and Prednisol, plus Prostap.
My recent PSA scores have been >0.1 (undetectable), but I have just had my third PSMA PET scan which shows that the activity in some of the the metasticised areas is increasing. This seems counter intuitive if the ADT medication has reduced the cancer activity?
Welcome any thoughts?
Stephen
Written by
Stephen399b
To view profiles and participate in discussions please or .
I think you mean <.1. Uptake seems unlikely to represent growing cancer to me. In rare instances PSA can be absent while cancer grows, though. What does your radiation incologist or MO say? Specifically what does it say under “IMPRESSION ?” This should also be posted under the Advanced Prostate Cancer section. Probably get more input.
>>> . . .In rare instances PSA can be absent while cancer grows, though.
>>>
I missed a lecture at my local support group, last year.
The gist of it, was that in advanced PCa, after several different treatments have failed, low-PSA cancer isn't "rare", but fairly common. I think the number mentioned was 10%-15%.
As they mutate, the tumor cells behave less and less like normal prostate cells, whose main purpose is to generate PSA.
Recent discussions appears you are right. I have a slide in a Dr. Kwon presentation that says 12% of his patients. Of course he is going to have serious cases. But how long before that begins? The OP has only been on first line hormone therapy 10 months or so.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.